KEWAUNEE SCIENTIFIC CORPKEQUEarnings & Financial Report
Kewaunee Scientific Corporation designs, manufactures, and installs specialized laboratory furniture, fume hoods, and integrated laboratory infrastructure solutions. It serves clients across pharmaceutical, biotech, academic research, healthcare, and industrial R&D segments, with core operations in North America and a steadily expanding global customer base.
KEQU Q2 FY2026 Key Financial Metrics
Revenue
$70.1M
Gross Profit
$19.7M
Operating Profit
$4.1M
Net Profit
$2.4M
Gross Margin
28.1%
Operating Margin
5.9%
Net Margin
3.5%
YoY Growth
46.8%
EPS
$0.82
KEWAUNEE SCIENTIFIC CORP Q2 FY2026 Financial Summary
KEWAUNEE SCIENTIFIC CORP reported revenue of $70.1M (up 46.8% YoY) for Q2 FY2026, with a net profit of $2.4M (down 18.7% YoY) (3.5% margin). Cost of goods sold was $50.4M, operating expenses totaled $15.6M.
Key Financial Metrics
| Total Revenue | $70.1M |
|---|---|
| Net Profit | $2.4M |
| Gross Margin | 28.1% |
| Operating Margin | 5.9% |
| Report Period | Q2 FY2026 |
Revenue Breakdown
KEWAUNEE SCIENTIFIC CORP Q2 FY2026 revenue of $70.1M breaks down across 3 segments, led by Transferred Over Time at $32.9M (47.0% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Transferred Over Time | $32.9M | 47.0% |
| Transferred At Point In Time | $22.3M | 31.8% |
| Other | $14.9M | 21.2% |
KEWAUNEE SCIENTIFIC CORP Revenue by Segment — Quarterly Trend
KEWAUNEE SCIENTIFIC CORP revenue by segment across the last 4 reported quarters, showing how each business line (such as Transferred Over Time and Transferred At Point In Time) has evolved quarter over quarter.
| Segment | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 |
|---|---|---|---|---|
| Transferred Over Time | $32.9M | $32.7M | $30.1M | $33.1M |
| Transferred At Point In Time | $22.3M | $21.6M | $25.4M | $18.9M |
| Other | $14.9M | $16.8M | $21.7M | $15.2M |
KEWAUNEE SCIENTIFIC CORP Annual Revenue by Year
KEWAUNEE SCIENTIFIC CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $240.5M).
KEWAUNEE SCIENTIFIC CORP Quarterly Revenue & Net Profit History
KEWAUNEE SCIENTIFIC CORP results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2026 | $70.1M | +46.8% | $2.4M | 3.5% |
| Q1 FY2026 | $71.1M | +46.9% | $3.1M | 4.3% |
| Q4 FY2025 | $77.1M | +36.1% | $4.8M | 6.3% |
| Q3 FY2025 | $67.2M | +43.6% | $1.4M | 2.0% |
| Q2 FY2025 | $47.8M | -5.3% | $3.0M | 6.3% |
| Q1 FY2025 | $48.4M | -2.9% | $2.2M | 4.5% |
| Q4 FY2024 | $56.7M | +5.0% | $11.0M | 19.4% |
| Q3 FY2024 | $46.8M | -23.1% | $2.5M | 5.4% |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $46.8M | $56.7M | $48.4M | $47.8M | $67.2M | $77.1M | $71.1M | $70.1M |
| YoY Growth | -23.1% | 5.0% | -2.9% | -5.3% | 43.6% | 36.1% | 46.9% | 46.8% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $126.3M | $134.8M | $132.0M | $134.5M | $189.1M | $194.7M | $193.5M | $189.1M |
| Liabilities | $81.0M | $78.6M | $74.5M | $73.8M | $127.0M | $128.4M | $124.6M | $117.4M |
| Equity | $44.1M | $54.8M | $56.0M | $59.3M | $60.8M | $64.5M | $67.1M | $69.9M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $9.5M | $1.1M | $-794000 | $8.4M | $-2.3M | $9.4M | $5.8M | $-4.3M |